Key result
Blocking angiotensin II type 1 receptors with candesartan and mineralocorticoid receptors with eplerenone prevented angiotensin II-induced oxidative DNA damage in the kidneys and hearts of mice.
Why the study?
Does blocking angiotensin II or mineralocorticoid receptors prevent oxidative DNA damage in the kidneys and hearts of angiotensin II-induced hypertensive mice?
Does blocking angiotensin II or mineralocorticoid receptors prevent oxidative DNA damage in the kidneys and hearts of angiotensin II-induced hypertensive mice?
Blocking the AT1 receptor or scavenging radicals prevents angiotensin II-induced oxidative DNA damage in the heart and kidneys of mice, independent of blood pressure normalization.
Should not change clinical hypertension practice; hypothesis-generating for AT1/MR blockade in oxidative damage.
Introduction: Recently, we could show that angiotensin II, the reactive peptide of the blood pressure-regulating renin-angiotensin-aldosterone-system, causes the formation of reactive oxygen species and DNA damage in kidneys and hearts of hypertensive mice. To further investigate on the one hand the mechanism of DNA damage caused by angiotensin II, and on the other hand possible intervention strategies against end-organ damage, the effects of substances interfering with the renin-angiotensin-aldosterone-system on angiotensin II-induced genomic damage were studied. Methods: In C57BL/6-mice, hypertension was induced by infusion of 600 ng/kg N min angiotensin II. The animals were additionally treated with the angiotensin II type 1 receptor blocker candesartan, the mineralocorticoid receptor blocker eplerenone and the antioxidant tempol. DNA damage and the activation of transcription factors were studied by immunohistochemistry and protein expression analysis. Results: Administration of angiotensin II led to a significant increase of blood pressure, decreased only by candesartan. In kidneys and hearts of angiotensin IItreated animals, significant oxidative stress could be detected (1.5-fold over control). The redox-sensitive transcription factors Nrf2 and NF-kB were activated in the kidney by angiotensin II-treatment (4-and 3-fold over control, respectively) and reduced by all interventions. In kidneys and hearts an increase of DNA damage (3and 2-fold over control, respectively) and of DNA repair (3-fold over control) was found. These effects were ameliorated by all interventions in both organs. Consistently, candesartan and tempol were more effective than eplerenone.
No takes yet. Share an insight, caveat, or question.
Brand et al. (2014) studied Hypertension (n=36). Candesartan, eplerenone, and tempol vs. Angiotensin II alone and PBS control was evaluated on DNA damage in kidneys and hearts. Blocking angiotensin II type 1 receptors with candesartan and mineralocorticoid receptors with eplerenone prevented angiotensin II-induced oxidative DNA damage in the kidneys and hearts of mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: